Evan Iverson - 08 May 2025 Form 4 Insider Report for Frontdoor, Inc. (FTDR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 May 2025, 16:03:58 UTC
Prior SEC filing
01 Apr 2025
Next SEC filing
03 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephanie Delavale, as Attorney-In-Fact for Evan Iverson

Key filing fact

Evan Iverson filed Form 4 for Frontdoor, Inc. (FTDR) on 12 May 2025.

Key facts

  • This page summarizes Evan Iverson's Form 4 filing for Frontdoor, Inc. (FTDR).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 May 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 01 Apr 2025.
  • Current net transaction value: -$618,068.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007420 Primary reporting owner

Iverson Evan

Relationship
SVP & Chief Operating Officer
Address
3400 PLAYERS CLUB PARKWAY, MEMPHIS
Signature
/s/ Stephanie Delavale, as Attorney-In-Fact for Evan Iverson
Signature date
12 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FTDR transaction

Common Stock

Options Exercise

Transaction value
$160,554
Shares
+6,077
Change %
+46%
Price
$26.42
Shares after
19,170
Date
08 May 2025
Ownership
Direct
FTDR transaction

Common Stock

Sale

Transaction value
$324,559
Shares
-6,077
Change %
-32%
Price
$53.41
Shares after
13,093
Date
08 May 2025
Ownership
Direct
Footnotes
F1
FTDR transaction

Common Stock

Sale

Transaction value
$454,063
Shares
-8,500
Change %
-65%
Price
$53.42
Shares after
4,593
Date
08 May 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FTDR transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-6,077
Change %
-21%
Price
$0.000000
Shares after
22,773
Date
08 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,077
Exercise price
$26.42
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $53.26 to $53.57, inclusive. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $53.26 to $53.61, inclusive. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F3

Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on March 27, 2023. The award includes three tranches of 6,077, 9,393 and 13,380 options respectively, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $32.23, $35.14 and $38.31, respectively, over any 20 consecutive trading-day period. The time-based vesting condition for all three tranches was satisfied on March 27, 2024. The performance-based vesting condition was satisfied on July 20, 2023, August 8, 2023 and August 2, 2024, respectively, as certified by the Compensation Committee of the Company's Board of Directors. The Reporting Person exercised the first tranche of the award which became exercisable on March 27, 2024; the second and third tranches of the award that became exercisable on March 27, 2024 and August 2, 2024, respectively, remain outstanding.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .